The Second Asia-Oceania Human Proteome Organization (AOHUPO) Online Education Series on the Renaissance of Clinical Proteomics: Biomarkers, Imaging and Therapeutics.


Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
12 2022
Historique:
received: 20 10 2022
accepted: 23 10 2022
pubmed: 30 10 2022
medline: 28 12 2022
entrez: 29 10 2022
Statut: ppublish

Résumé

In 2021, the Asia-Oceania Human Proteome Organization (AOHUPO) initiated a new endeavor named the AOHUPO Online Education Series with the aim to promote scientific education and collaboration, exchange of ideas and culture among the young scientists in the AO region. Following the warm participation, the AOHUPO organized the second series in 2022, with the theme "The Renaissance of Clinical Proteomics: Biomarkers, Imaging and Therapeutics". This time, the second AOHUPO Online Education Series was hosted by the UKM Medical Molecular Biology Institute (UMBI) affiliated to the National University of Malaysia (UKM) in Kuala Lumpur, Malaysia on three consecutive Fridays (11th, 18th and 25th of March). More than 300 participants coming from 29 countries/regions registered for this 3-days event. This event provided an amalgamation of six prominent speakers and all participants whose interests lay mainly in applying MS-based and non-MS-based proteomics for clinical investigation.

Identifiants

pubmed: 36309314
pii: S1535-9476(22)00244-4
doi: 10.1016/j.mcpro.2022.100436
pmc: PMC9700300
pii:
doi:

Substances chimiques

Proteome 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100436

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflict of interest with the contents of this article.

Auteurs

Teck Yew Low (TY)

UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Yu-Ju Chen (YJ)

Institute of Chemistry, Academia Sinica, Taipei, Taiwan.

Yasushi Ishihama (Y)

Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.

Max Ching Ming Chung (MCM)

Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Stuart Cordwell (S)

School of Life and Environmental Sciences and Sydney Mass Spectrometry, The University of Sydney, Sydney, Australia.

Terence Chuen Wai Poon (TCW)

Pilot Laboratory, Proteomics Core, Institute of Translational Medicine, Centre for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau SAR, China.

Ho Jeong Kwon (HJ)

Chemical Genomics Leader Research Initiative, Department of Biotechnology, Yonsei University, Seoul, South Korea. Electronic address: kwonhj@yonsei.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH